Methadone treatment providers’ views of drug court policy and practice: a case study of New York State

[1]  J. Rich,et al.  Overcoming obstacles to implementing methadone maintenance therapy for prisoners: implications for policy and practice. , 2018, Journal of opioid management.

[2]  R. Mattick,et al.  Buprenorphine maintenance versus placebo or methadone maintenance for opioid dependence. , 2014, The Cochrane database of systematic reviews.

[3]  J. Montaner,et al.  A call for evidence-based medical treatment of opioid dependence in the United States and Canada. , 2013, Health affairs.

[4]  K. O’grady,et al.  Opioid agonist treatments and heroin overdose deaths in Baltimore, Maryland, 1995-2009. , 2013, American journal of public health.

[5]  D. Marlowe,et al.  Medication assisted treatment in US drug courts: results from a nationwide survey of availability, barriers and attitudes. , 2012, Journal of substance abuse treatment.

[6]  L. Dixon,et al.  Use of a 'microecological technique' to study crime incidents around methadone maintenance treatment centers. , 2012, Addiction.

[7]  P. Friedmann,et al.  Medication-Assisted Treatment in Criminal Justice Agencies Affiliated with the Criminal Justice-Drug Abuse Treatment Studies (CJ-DATS): Availability, Barriers, and Intentions , 2012, Substance abuse.

[8]  T. Kresina,et al.  Improving Public Health Through Access to and Utilization of Medication Assisted Treatment , 2011, International journal of environmental research and public health.

[9]  B. Tempalski,et al.  Distance Traveled and Cross-State Commuting to Opioid Treatment Programs in the United States , 2011, Journal of environmental and public health.

[10]  D. Marlowe.  Research Update on Adult Drug Courts , 2010 .

[11]  Randall T Brown.  Systematic review of the impact of adult drug-treatment courts. , 2010, Translational research : the journal of laboratory and clinical medicine.

[12]  R P Mattick,et al.  Methadone maintenance therapy versus no opioid replacement therapy for opioid dependence. , 2009, The Cochrane database of systematic reviews.

[13]  R. Burkhard,et al.  Microenvironment Analysis of a University Campus: GIS Design Considerations for Process Repeatability , 2009 .

[14]  H. Kleber.  Methadone maintenance 4 decades later: thousands of lives saved but still controversial. , 2008, JAMA.

[15]  T. Clausen,et al.  Mortality prior to, during and after opioid maintenance treatment (OMT): a national prospective cross-registry study. , 2008, Drug and alcohol dependence.

[16]  T. D’Aunno.  The role of organization and management in substance abuse treatment: Review and roadmap. , 2006, Journal of substance abuse treatment.

[17]  P. Hora.  Trading One Drug for Another? What Drug Treatment Court Professionals Need to Learn About Opioid Replacement Therapy , 2005 .

[18]  M. Parrino.  Drug court fact sheet: Methadone maintenance and other pharmacotherapeutic interventions in the treatment of opioid dependence , 2003 .

[19]  S. Stancliff,et al.  Methadone maintenance treatment (MMT): a review of historical and clinical issues. , 2000, The Mount Sinai journal of medicine, New York.

[20]  H. W. Clark,et al.  Methadone maintenance vs 180-day psychosocially enriched detoxification for treatment of opioid dependence: a randomized controlled trial. , 2000, JAMA.

[21]  D. Marlowe,et al.  PAINTING THE CURRENT PICTURE: A NATIONAL REPORT ON DRUG COURTS AND OTHER PROBLEM-SOLVING COURT PROGRAMS IN THE UNITED STATES , 2011 .

[22]  M. Agar,et al.  Why don't out-of-treatment individuals enter methadone treatment programmes? , 2010, The International journal on drug policy.

[23]  Hon. Judy Harris Kluger.  New York State Problem-Solving Courts: Drug Treatment Courts 2007 Annual Report , 2007 .

[24]  C. Cooper.  Drug courts: current issues and future perspectives. , 2003, Substance use & misuse.

[25]  M. Rempel,et al.  Executive Summary : The New York State Adult Drug Court Evaluation Policies , Participants and Impacts , 2003 .

[26]  M. Rempel,et al.  The New York State Adult Drug Court Evaluation: Policies, Participants and Impacts: (640692007-001) , 2003 .